Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Wilms Tumor 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Sezary Syndrome 1Seminoma 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Hodgkin Disease 1Endodermal Sinus Tumor 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1

Interventions

Ibandronic Acid 4Zoledronic Acid 3Tranexamic Acid 2ridaforolimus 1dinutuximab 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Neutrons 1Fluoridation 1Fibrin Tissue Adhesive 1Diathermy 1Denosumab 1Cyproheptadine 1Cefazolin 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bone Neoplasms × Captopril × Clear all
NCT03389724 2022-11-08

Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia

Children's Cancer Hospital Egypt 57357

Phase 3 Completed
245 enrolled
Sarcoma

Bone Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡